Authors:
Stupp, R
Bodmer, A
Duvoisin, B
Bauer, J
Perey, L
Bakr, M
Ketterer, N
Leyvraz, S
Citation: R. Stupp et al., Is cisplatin required for the treatment of non-small-cell lung cancer? Experience and preliminary results of a phase I/II trial with topotecan and vinorelbine, ONCOL-BASEL, 61, 2001, pp. 35-41
Authors:
Dearden, CE
Matutes, E
Cazin, B
Tjonnfjord, GE
Parreira, A
Nomdedeu, B
Leoni, P
Clark, FJ
Radia, D
Rassam, SMB
Roques, T
Ketterer, N
Brito-Babapulle, V
Dyer, MJS
Catovsky, D
Citation: Ce. Dearden et al., High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H, BLOOD, 98(6), 2001, pp. 1721-1726
Authors:
Ketterer, N
Sonet, A
Dumontet, C
Moullet, I
Thieblemont, C
Espinouse, D
Bouafia, F
Coiffier, B
Salles, G
Citation: N. Ketterer et al., Toxicities after peripheral blood progenitor cell transplantation for lymphoid malignancies: analysis of 300 cases in a single institution, BONE MAR TR, 23(12), 1999, pp. 1309-1315
Authors:
Ketterer, N
Espinouse, D
Chomarat, M
Dumontet, C
Moullet, I
Rieux, C
Neidhardt-Berard, EM
Bouafia, F
Coiffier, B
Salles, G
Citation: N. Ketterer et al., Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: Etiology and potential risk factors, AM J MED, 106(2), 1999, pp. 191-197